SEC Sues Imaging3 For Misleading Investors About FDA Device Review
This article was originally published in The Gray Sheet
Executive Summary
The Securities and Exchange Commission says the imaging equipment firm’s founder and CEO made misleading public statements about the contents of a 2010 “not substantially equivalent” letter from FDA for Imaging3’s investigational Dominion 3-D, real-time imaging system.